MiR-365 regulates lung cancer and developmental gene thyroid transcription factor 1

Cell Cycle

Volumn 11, Issue 1, 2012, Pages 177-186

  Qi, Ji ^a   Rice, Shawn J ^a   Salzberg, Anna C ^a   Runkle, E Aaron ^a   Liao, Jason ^a   Zander, Dani S ^a   Mu, David ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

14q13; HMGA2; Lung cancer; Lung development; miR 365; NKX2 1; TGF ; TTF 1

Indexed keywords

HIGH MOBILITY GROUP A2 PROTEIN; MICRORNA; MICRORNA 365; RNA PRECURSOR; THYROID TRANSCRIPTION FACTOR 1; TRANSFORMING GROWTH FACTOR BETA; TUMOR MARKER; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; EPITHELIAL MESENCHYMAL TRANSITION; GENE AMPLIFICATION; GENE DOSAGE; GENE EXPRESSION PROFILING; GENE LOCUS; GENETIC SELECTION; GENOMICS; HUMAN; LUNG CANCER;

EID: 84855685246     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.11.1.18576     Document Type: Article

References (49)

1. Maeda Y, Dave V, Whitsett JA. Transcriptional control of lung morphogenesis. Physiol Rev 2007; 87:219-44; PMID:17237346; http://dx.doi.org/10. 1152/physrev.00028.2006.
2. Ordóñez NG. Thyroid transcription factor-1 is a marker of lung and thyroid carcinomas. Adv Anat Pathol 2000; 7:123-7; PMID:10721419; http://dx.doi.org/10.1097/00125480-200007020-00007.
3. Guazzi S, Price M, De Felice M, Damante G, Mattei MG, Di Lauro R. Thyroid nuclear factor 1 (TTF-1) contains a homeodomain and displays a novel DNA binding specificity. EMBO J 1990; 9:3631-9; PMID:1976511.
4. Kimura S, Hara Y, Pineau T, Fernandez-Salguero P, Fox CH, Ward JM, et al. The T/ebp null mouse: thyroidspecific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain and pituitary. Genes Dev 1996; 10:60-9; PMID:8557195; http://dx.doi.org/10.1101/gad.10.1.60.
5. DeFelice M, Silberschmidt D, DiLauro R, Xu Y, Wert SE, Weaver TE, et al. TTF-1 phosphorylation is required for peripheral lung morphogenesis, perinatal survival and tissue-specific gene expression. J Biol Chem 2003; 278:35574-83; PMID:12829717; http://dx.doi.org/10.1074/jbc.M304885200.
6. Kendall J, Liu Q, Bakleh A, Krasnitz A, Nguyen KC, Lakshmi B, et al. Oncogenic cooperation and coamplification of developmental transcription factor genes in lung cancer. Proc Natl Acad Sci USA 2007; 104:16663-8; PMID:17925434; http://dx.doi.org/10.1073/pnas.0708286104.
7. Kwei KA, Kim YH, Girard L, Kao J, Pacyna-Gengelbach M, Salari K, et al. Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer. Oncogene 2008; 27:3635-40; PMID:18212743; http://dx.doi.org/10. 1038/sj.onc.1211012.
8. Tanaka H, Yanagisawa K, Shinjo K, Taguchi A, Maeno K, Tomida S, et al. Lineage-specific dependency of lung adenocarcinomas on the lung development regulator TTF-1. Cancer Res 2007; 67:6007-11; PMID:17616654; http://dx.doi.org/10.1158/0008-5472.CAN-06-4774.
9. Weir BA, Woo MS, Getz G, Perner S, Ding L, Beroukhim R, et al. Characterizing the cancer genome in lung adenocarcinoma. Nature 2007; 450:893-8; PMID:17982442; http://dx.doi.org/10.1038/nature06358.
10. Perner S, Wagner PL, Soltermann A, LaFargue C, Tischler V, Weir BA, et al. TTF1 expression in non-small cell lung carcinoma: association with TTF1 gene amplification and improved survival. J Pathol 2009; 217:65-72; PMID:18932182; http://dx.doi.org/10.1002/path.2443.
11. Hsu DS, Acharya CR, Balakumaran BS, Riedel RF, Kim MK, Stevenson M, et al. Characterizing the developmental pathways TTF-1, NKX2-8 and PAX9 in lung cancer. Proc Natl Acad Sci USA 2009; 106:5312-7; PMID:19279207; http://dx.doi.org/10.1073/pnas.0900827106.
12. Winslow MM, Dayton TL, Verhaak RGW, Kim-Kiselak C, Snyder EL, Feldser DM, et al. Suppression of lung adenocarcinoma progression by Nkx2-1. Nature 2011; 473:101-4; PMID:21471965; http://dx.doi.org/10.1038/nature09881.
13. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136:215-33; PMID:19167326; http://dx.doi.org/10.1016/j.cell.2009.01.002.
14. Croce CM. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 2009; 10:704-14; PMID:19763153; http://dx.doi.org/10.1038/nrg2634.
15. He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation 2004; 5:522-31.
16. Bartel DP. MicroRNAs: Genomics, Biogenesis, Mechanism and Function. Cell 2004; 116:281-97; PMID:14744438; http://dx.doi.org/10.1016/S0092-8674(04)00045- 5.
17. Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T. Identification of novel genes coding for small expressed RNAs. Science 2001; 294:853-8; PMID:11679670; http://dx.doi.org/10.1126/science.1064921.
18. Melo SA, Esteller M. A precursor microRNA in a cancer cell nucleus: get me out of here! Cell Cycle 2011; 10:922-5; PMID:21346411; http://dx.doi.org/10. 4161/cc.10.6.15119.
19. Bhaskaran M, Wang Y, Zhang H, Weng T, Baviskar P, Guo Y, et al. MicroRNA-127 modulates fetal lung development. Physiol Genomics 2009; 37:268-78; PMID:19439715; http://dx.doi.org/10.1152/physiolgenomics.90268.2008.
20. Lizé M, Herr C, Klimke A, Bals R, Dobbelstein M. MicroRNA-449a levels increase by several orders of magnitude during mucociliary differentiation of airway epithelia. Cell Cycle 2010; 9:4579-83; PMID:21088493; http://dx.doi.org/10.4161/cc.9.22.13870.
21. Kumar MS, Erkeland SJ, Pester RE, Chen CY, Ebert MS, Sharp PA, et al. Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc Natl Acad Sci USA 2008; 105:3903-8; PMID:18308936; http://dx.doi.org/10.1073/pnas.0712321105.
22. Sozzi G, Pastorino U, Croce CM. MicroRNAs and lung cancer: from markers to targets. Cell Cycle 2011; 10:2045-6; PMID:21623159; http://dx.doi.org/10. 4161/cc.10.13.15712.
23. Yu SL, Chen HY, Chang GC, Chen CY, Chen HW, Singh S, et al. MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell 2008; 13:48-57; PMID:18167339; http://dx.doi.org/10.1016/j.ccr.2007.12.008.
24. Pacheco-Pinedo EC, Morrisey EE. Wnt and Kras signaling-dark siblings in lung cancer. Oncotarget 2011; 2:569-74; PMID:21753228.
25. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 2007; 27:91-105; PMID:17612493; http://dx.doi.org/10.1016/j.molcel.2007. 06.017.
26. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ. miRBase: tools for microRNA genomics. Nucleic Acids Res 2008; 36:154-8; PMID:17991681; http://dx.doi.org/10.1093/nar/gkm952.
27. Saito RA, Watabe T, Horiguchi K, Kohyama T, Saitoh M, Nagase T, et al. Thyroid Transcription Factor-1 Inhibits Transforming Growth Factor-{beta}- Mediated Epithelial-to-Mesenchymal Transition in Lung Adenocarcinoma Cells. Cancer Res 2009; 69:2783-91; PMID:19293183; http://dx.doi.org/10.1158/0008-5472. CAN-08-3490.
28. Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009; 19:92-105; PMID:18955434; http://dx.doi.org/10.1101/gr.082701.108.
29. Lewis BP, Burge CB, Bartel DP. Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets. Cell 2005; 120:15-20; PMID:15652477; http://dx.doi.org/10.1016/j.cell.2004.12.035.
30. Bar M, Wyman SK, Fritz BR, Qi J, Garg KS, Parkin RK, et al. MicroRNA discovery and profiling in human embryonic stem cells by deep sequencing of small RNA libraries. Stem Cells 2008; 26:2496-505; PMID:18583537; http://dx.doi.org/10.1634/stemcells.2008-0356.
31. Simon RM, Korn EL, McShane LM, Radmacher MD, Wright GW, Zhao Y. Design and analysis of DNA microarray investigations. Springer 2003.
32. Enright AJ, John B, Gaul U, Tuschl T, Sander C, Marks DS. MicroRNA targets in Drosophila. Genome Biol 2003; 5:1; PMID:14709173; http://dx.doi.org/10.1186/gb-2003-5-1-r1.
33. Anagnostou VK, Syrigos KN, Bepler G, Homer RJ, Rimm DL. Thyroid transcription factor 1 is an independent prognostic factor for patients with stage I lung adenocarcinoma. J Clin Oncol 2009; 27:271-8; PMID:19064983; http://dx.doi.org/10.1200/JCO.2008.17.0043.
34. Barletta JA, Perner S, Iafrate AJ, Yeap BY, Weir BA, Johnson LA, et al. Clinical significance of TTF-1 protein expression and TTF-1 gene amplification in lung adenocarcinoma. J Cell Mol Med 2009; 13:1977-86; PMID:19040416; http://dx.doi.org/10.1111/j.1582-4934.2008.00594.x.
35. Reddel RR, Ke Y, Gerwin BI, McMenamin MG, Lechner JF, Su RT, et al. Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes. Cancer Res 1988; 48:1904-9; PMID:2450641.
36. Fusco A, Fedele M. Roles of HMGA proteins in cancer. Nat Rev Cancer 2007; 7:899-910; PMID:18004397; http://dx.doi.org/10.1038/nrc2271.
37. Lee YS, Dutta A. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev 2007; 21:1025-30; PMID:17437991; http://dx.doi.org/10.1101/ gad.1540407.
38. Mayr C, Hemann MT, Bartel DP. Disrupting the Pairing Between let-7 and Hmga2 Enhances Oncogenic Transformation. Science 2007; 315:1576-9; PMID:17322030; http://dx.doi.org/10.1126/science.1137999.
39. Park SM, Shell S, Radjabi AR, Schickel R, Feig C, Boyerinas B, et al. Let-7 Prevents Early Cancer Progression by Suppressing Expression of the Embryonic Gene HMGA2. Cell Cycle 2007; 6:2585-90; PMID:17957144; http://dx.doi.org/10.4161/cc.6.21.4845.
40. Ambros V. The functions of animal microRNAs. Nature 2004; 431:350-5; PMID:15372042; http://dx.doi.org/10.1038/nature02871.
41. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993; 75:843-54; PMID:8252621; http://dx.doi.org/10.1016/0092-8674(93)90529-Y.
42. Zhang Y, Verbeek FJ. Comparison and integration of target prediction algorithms for microRNA studies. J Integr Bioinform 2010; 7.
43. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 2004; 101:2999-3004; PMID:14973191; http://dx.doi.org/10.1073/pnas.0307323101.
44. Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6:259-69; PMID:16557279; http://dx.doi.org/10.1038/ nrc1840.
45. Lee YS, Dutta A. MicroRNAs in cancer. Annu Rev Pathol 2009; 4:199-227; PMID:18817506; http://dx.doi.org/10.1146/annurev.pathol.4.110807.092222.
46. Homminga I, Pieters R, Langerak Anton W, de Rooi Johan J, Stubbs A, Verstegen M, et al. Integrated Transcript and Genome Analyses Reveal NKX2-1 and MEF2C as Potential Oncogenes in T Cell Acute Lymphoblastic Leukemia. Cancer Cell 2011; 19:484-97; PMID:21481790; http://dx.doi.org/10.1016/j.ccr.2011.02.008.
47. Kang Y, Hebron H, Ozbun L, Mariano J, Minoo P, Jakowlew SB. Nkx2.1 transcription factor in lung cells and a transforming growth factor-β1 heterozygous mouse model of lung carcinogenesis. Mol Carcinog 2004; 40:212-31; PMID:15264213; http://dx.doi.org/10.1002/mc.20034.
48. Harris T, Pan Q, Sironi J, Lutz D, Tian J, Sapkar J, et al. Both gene amplification and allelic loss occur at 14q13.3 in lung cancer. Clin Cancer Res 2011; In press; PMID:21148747; http://dx.doi.org/10.1158/1078-0432.CCR-10-1892.
49. Minoo P, Hu L, Zhu N, Borok Z, Bellusci S, Groffen J, et al. SMAD3 prevents binding of NKX2.1 and FOXA1 to the SpB promoter through its MH1 and MH2 domains. Nucleic Acids Res 2008; 36:179-88; PMID:18003659; http://dx.doi.org/ 10.1093/nar/gkm871.